Immune checkpoint inhibitor-related liver toxicity.
作者信息
Bolte Fabian J, Hall Richard D, Shah Neeral L
机构信息
Department of Internal Medicine University of Virginia Charlottesville Virginia USA.
Division of Hematology and Oncology University of Virginia Charlottesville Virginia USA.
出版信息
Clin Liver Dis (Hoboken). 2022 Jul 16;20(3):93-96. doi: 10.1002/cld.1241. eCollection 2022 Sep.
Abstract
Content available: Audio Recording.
摘要
相似文献
1
Immune checkpoint inhibitor-related liver toxicity.
Clin Liver Dis (Hoboken). 2022 Jul 16;20(3):93-96. doi: 10.1002/cld.1241. eCollection 2022 Sep.
2
Clinical and Pathological Features of Immune Checkpoint Inhibitor-induced Liver Injury in Comparison with Drug-induced Liver Injury and Autoimmune Hepatitis.
J Gastrointestin Liver Dis. 2023 Dec 22;32(4):488-496. doi: 10.15403/jgld-5045.
3
Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team.
Hepatol Res. 2024 Nov;54(11):1060-1069. doi: 10.1111/hepr.14043. Epub 2024 Apr 4.
4
The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity.
Int J Mol Sci. 2024 Jun 27;25(13):7013. doi: 10.3390/ijms25137013.
5
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors.
JHEP Rep. 2020 Aug 11;2(6):100170. doi: 10.1016/j.jhepr.2020.100170. eCollection 2020 Dec.
6
Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy.
Gastroenterol Rep (Oxf). 2019 Dec 17;8(1):25-30. doi: 10.1093/gastro/goz065. eCollection 2020 Feb.
7
Application of artificial liver in immune-related liver injury induced by immune checkpoint inhibitor: Case reports and review of the literature.
Front Immunol. 2022 Sep 2;13:1001823. doi: 10.3389/fimmu.2022.1001823. eCollection 2022.
8
Evaluation of the safety and immunological effects of Bacillus Calmette-Guérin in combination with checkpoint inhibitor therapy in a patient with neuroendocrine carcinoma: a case report.
J Med Case Rep. 2023 Sep 4;17(1):377. doi: 10.1186/s13256-023-04117-3.
9
Workup and Management of Immune-Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment.
Oncologist. 2020 Feb;25(2):105-111. doi: 10.1634/theoncologist.2018-0162. Epub 2019 Sep 9.
10
Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.
Ther Adv Drug Saf. 2021 Mar 29;12:20420986211004745. doi: 10.1177/20420986211004745. eCollection 2021.
本文引用的文献
1
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002435.
2
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors.
JHEP Rep. 2020 Aug 11;2(6):100170. doi: 10.1016/j.jhepr.2020.100170. eCollection 2020 Dec.
3
Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.
Lancet Oncol. 2020 Aug;21(8):e398-e404. doi: 10.1016/S1470-2045(20)30107-8.
4
Immune-related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
Liver Int. 2020 Aug;40(8):1906-1916. doi: 10.1111/liv.14489. Epub 2020 Jun 3.
5
The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study.
Eur J Cancer. 2020 May;130:39-50. doi: 10.1016/j.ejca.2020.02.010. Epub 2020 Mar 12.
6
A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors.
Int J Cancer. 2019 Aug 1;145(3):639-648. doi: 10.1002/ijc.32132. Epub 2019 Feb 4.
7
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
JAMA Oncol. 2018 Dec 1;4(12):1721-1728. doi: 10.1001/jamaoncol.2018.3923.
8
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14.
9
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
J Hepatol. 2018 Jun;68(6):1181-1190. doi: 10.1016/j.jhep.2018.01.033. Epub 2018 Feb 8.
10
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481.
Zotero 插件